Budget 2024: Drugmakers want Nirmala Sitharaman to prescribe tax relief tablet for the economy
Drugs body flags side effects of heart, Glaucoma medications Dr Reddy's, Sun Pharma recall drugs in US market: USFDA AstraZeneca to invest Rs 250 crore on expansion of its GCC in India - Alembic Pharma gets tentative nod from USFDA for Ivosidenib tablets
- Zydus Lifesciences gets tentative approval from USFDA for BP lowering drug
- Waiting for a wonder drug? The weight just got longer
- Warning letter: USFDA pulls up Sun Pharma for manufacturing issues at Dadra facility
- EU approves Sanofi's Dupixent for 'smoker's lungs'
- Weekly-once insulin jab may soon come to India
- Wockhardt aims to launch antibiotic with USD 25 bn mkt potential by early FY26
- India to make drugs for diabetes, obesity under PLI by 2026, says report
- Risk-based audits of drug units to begin from July 1
- Indian regulator says 36% of inspected drug-making units had to be shut
- Indian Pharma exports: 'USD 10 billion opportunity up for grabs in off patent drug market by 2029'
ADVERTISEMENT